Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 5;10(1):4159.
doi: 10.1038/s41598-020-61048-5.

Adapting SureSelect enrichment protocol to the Ion Torrent S5 platform in molecular diagnostics of craniosynostosis

Affiliations

Adapting SureSelect enrichment protocol to the Ion Torrent S5 platform in molecular diagnostics of craniosynostosis

Ewelina Bukowska-Olech et al. Sci Rep. .

Abstract

Obtaining reliable and high fidelity next-generation sequencing (NGS) data requires to choose a suitable sequencing platform and a library preparation approach, which both have their inherent assay-specific limitations. Here, we present the results of successful adaptation of SureSelect hybridisation-based target enrichment protocol for the sequencing on the Ion Torrent S5 platform, which is designed to work preferably with amplicon-based panels. In our study, we applied a custom NGS panel to screen a cohort of 16 unrelated patients affected by premature fusion of the cranial sutures, i.e. craniosynostosis (CS). CS occurs either as an isolated malformation or in a syndromic form, representing a genetically heterogeneous and clinically variable group of disorders. The approach presented here allowed us to achieve high quality NGS data and confirmed molecular diagnosis in 19% of cases, reaching the diagnostic yield similar to some of the published research reports. In conclusion, we demonstrated that an alternative enrichment strategy for library preparations can be successfully applied prior to sequencing on the Ion Torrent S5 platform. Also, we proved that the custom NGS panel designed by us represents a useful and effective tool in the molecular diagnostics of patients with CS.

PubMed Disclaimer

Conflict of interest statement

Bartosz Wojciechowicz is a full-time employee of Perlan sp. z o.o., Perlan Technologies is an authorised distributor of Agilent Technologies in Poland.

Figures

Figure 1
Figure 1
Comparison of per-base coverage depth for all samples. Additional horizontal line indicates 95% of total bases in panel target regions.
Figure 2
Figure 2
Clinical characteristics at the age of 12 months (a,b) as well as molecular results of Patient 1 (c,d). Patient 1, in addition to sagittal craniosynostosis, maxillary hypoplasia, high palate and proptosis, presented with broad halluces and skin syndactyly of 2nd and 3rd toes (a). X-ray of the feet showed small hypoplastic middle phalanges of all toes, relative widening of 1st metatarsals and broadening of phalangeal bones forming halluces, and no bone syndactyly of 2nd and 3rd toes (b) Representation of the heterozygous FGFR2 deleterious variant c.868T > G p.Trp290Gly detected in Patient 1 by means of targeted next-generation sequencing (c) and validation studies of the proband and parental testing of the FGFR2 gene with the use of Sanger sequencing (d). Pathogenic variant c.868T > G p.Trp290Gly was confirmed in the index case and excluded in his unaffected parents, clearly indicating a de novo occurrence.
Figure 3
Figure 3
Clinical characteristics at the age of 2 years (a) and 6 years (b,c) as well as molecular results of Patient 7 (d,e). Patient 7 presented with complex craniosynostosis involving sagittal and bilateral coronal synostosis, dolichocephaly, macrocephaly, prominent forehead (a), flat face, proptosis (full facial picture not shown),brachydactyly and broad halluces (b,c). Representation of the heterozygous FGFR2 deleterious variant c.1694A > G p.Glu565Gly unraveled in Patient 7 by means of targeted next-generation sequencing (d) and validation studies of the proband and parental testing of the FGFR2 gene with the use of Sanger sequencing (e). Pathogenic variant c.1694A > G p.Glu565Gly was confirmed in the index case and excluded in his unaffected parents, clearly indicating a de novo occurrence.
Figure 4
Figure 4
Clinical characteristics of Patient 15 at the age of 11 (a–d) and 9.5 years (e,f) as well as molecular results of the patient (g-j). Patient 15 presented with complex craniosynostosis composed of bilateral coronal synostosis (complete right-sided and partial left-sided) as well as partial left-sided lambdoid synostosis shown in 3D modelling of the skull (a–c). CT scan of the head (d). Coronal sutures are prematurely fused. The right coronal suture is completely fused (a), while the left one is only partially fused (b); consequently, there is marked enlargement of the anterior fontanelle and widening of the sagittal suture, (a,c). Asymmetry of the skull and brain, including lateral ventricles, and enlargement of left subarachnoid space seen on horizontal section (d). Limb defect clinically recognized as bilateral split foot malformation with syndactyly of the remaining toes, extremely short and hypoplastic thumbs and 5th fingers, short 5th metacarpals and valgus deformity of the right 2nd finger (e,f). Representation of the compound heterozygous RECQL4 deleterious variants c.308C > T p.Pro103Leu and 3062G > A p.Arg1021Gln detected in Patient 15 by means of targeted next-generation sequencing (g,i). Both pathogenic variants were confirmed with the use of Sanger sequencing (h,j).

References

    1. Zemojtel, T. et al. Phenotype Analysis of the Disease-Associated Genome. 6 (2015).
    1. Bell CJ, et al. Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing. Sci. Transl. Med. 2013;3:1–46. - PMC - PubMed
    1. Yang Y, et al. Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders. N. Engl. J. Med. 2013;369:1502–1511. doi: 10.1056/NEJMoa1306555. - DOI - PMC - PubMed
    1. Glotov AS, et al. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group. Clin. Chim. Acta. 2015;446:132–140. doi: 10.1016/j.cca.2015.04.014. - DOI - PubMed
    1. Thuresson Ann‐Charlotte, Soussi Zander Cecilia, Zhao Jin J., Halvardson Jonatan, Maqbool Khurram, Månsson Else, Stenninger Eric, Holmlund Ulrika, Öhrner Ylva, Feuk Lars. Whole genome sequencing of consanguineous families reveals novel pathogenic variants in intellectual disability. Clinical Genetics. 2018;95(3):436–439. doi: 10.1111/cge.13470. - DOI - PMC - PubMed

Publication types